Canopy Growth CBD Worm Study Shows Promise
Long-term Testing in Worms Reveals CBD Extends Their Lives – LPC
Canada’s doctors — and doctors around the world — want to know more about cannabis risks and benefits. There isn’t even a standard cannabis unit that doctors can prescribe. But a new CBD worm study shows promise to reveal at least something about its safety.
Canopy Growth Corp. just completed one of the first major studies on the lifelong effects of CBD use and found it lengthens life and increases activity in old age — well, in worms.
While the results were promising, the use of organisms with two-week lifespans shows just how hard the industry is working to try and keep up with demand for hard science, which has been outpaced by consumer hype. After all, CBD is already used by millions of people around the world for conditions like insomnia and anxiety, and there’s been little research in humans on its long-term safety or even its effectiveness.
The US Food and Drug Administration )FDA) said this past week that the substance’s varying effects on men and women will influence its regulation, but has yet to lay out just how. For now, that’s leaving companies like Canopy to fill the research gap, which could ultimately help the FDA decide how to regulate it in the United States. Its CBD worm study is one step along that path.
Click here to view full story at www.bloomberg.com
This editorial content from the LPC News Team provides analysis, insight, and perspective on current news articles. To read the source article this commentary is based upon, please click on the link below. Are you part of the legal cannabis industry in Canada? Add Your Listing and get found by a qualified audience.
